Lipocine Inc.·4

Apr 6, 6:33 PM ET

Patel Mahesh V. 4

4 · Lipocine Inc. · Filed Apr 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Lipocine (LPCN) CEO Mahesh V. Patel Buys Stock

What Happened Mahesh V. Patel, CEO of Lipocine Inc. (LPCN), reported a purchase of 25,000 shares on April 6, 2026. The shares were acquired at $2.03 per share for a total reported transaction value of $50,750. The Form 4 lists the transaction type as a purchase (code P), indicating an open market or private purchase.

Key Details

  • Transaction date: 2026-04-06
  • Price per share: $2.03
  • Shares acquired: 25,000
  • Total value: $50,750
  • Transaction code: P (purchase — open market or private purchase)
  • Shares owned after the transaction: Not specified in the provided summary; see the filed Form 4 for total beneficial ownership
  • Footnotes / special plans: No 10b5-1 plan, tax withholding, or other footnotes noted in the provided summary
  • Filing info: Form filed Apr 6, 2026 (Accession No. 0001493152-26-015357); filing appears timely based on report date

Context Purchases by executives are often watched by investors as a potential sign of confidence, though they do not guarantee future performance. This was a straight equity purchase (not an option exercise, gift, or award). For full ownership details and any additional disclosures, retail investors should review the complete Form 4 filing available via the SEC EDGAR system.

Insider Transaction Report

Form 4
Period: 2026-04-06
Patel Mahesh V.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common stock

    2026-04-06$2.03/sh+25,000$50,750160,679 total
Signature
/s/ Mahesh V. Patel|2026-04-06

Documents

1 file
  • 4
    ownership.xmlPrimary

    4